Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3090758 | 0.91 | CYSLTR2 (0.79) | CYSLTR2CYSLTR1 | |
| SCHEMBL3095768 | 0.91 | CYSLTR2 (0.70) | CYSLTR2CYSLTR1 | |
| SCHEMBL3099540 | 0.88 | CYSLTR2 (0.85) | CYSLTR2CYSLTR1 | |
| SCHEMBL3092315 | 0.87 | CYSLTR2 (1.00) | CYSLTR2CYSLTR1 | |
| SCHEMBL3102855 | 0.87 | CYSLTR2 (1.00) | CYSLTR2CYSLTR1 | |
| SCHEMBL3099409 | 0.87 | CYSLTR2 (1.00) | CYSLTR2CYSLTR1 | |
| SCHEMBL3088294 | 0.87 | CYSLTR2 (0.77) | CYSLTR2CYSLTR1 | |
| SCHEMBL3102893 | 0.86 | CYSLTR2 (0.68) | CYSLTR2CYSLTR1 | |
| SCHEMBL3102804 | 0.85 | CYSLTR2 (0.89) | CYSLTR2CYSLTR1 | |
| SCHEMBL3082032 | 0.85 | CYSLTR2 (0.89) | CYSLTR2CYSLTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8318952-B2 | Substituted indole derivatives for the treatment of respiratory diseases | ONO PHARMACEUTICAL CO., LTD. (JP) | 2012-11-27 | — | — | US | disclosed |
| US-20100234368-A1 | CONDENSED RING COMPOUND AND USE THEREOF | TAKEUCHI JUN | 2010-09-16 | — | — | US | disclosed |
| US-7763610-B2 | Carboxylic acid derived benzoxazines as agents for the treatment of respiratory diseases | ONO PHARMACEUTICAL CO., LTD. (JP) | 2010-07-27 | — | — | US | disclosed |
| US-20060194797-A1 | Condensed ring compound and use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2006-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234368-A1 | CONDENSED RING COMPOUND AND USE THEREOF | CYSLTR2, CYSLTR1, LTB4R2 | CYSLTR2 1/4885CYSLTR1 2/4885 |
| US-20060194797-A1 | Condensed ring compound and use thereof | CYSLTR2, CYSLTR1, LTB4R2 | CYSLTR2 1/4885CYSLTR1 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.